MitoChem Therapeutics

company

About

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$2M
Industries
Biotechnology,Health Care,Life Science,Neuroscience,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative disease.

It was founded by Craig Beeson and Bärbel Rohrer in Charleston, South Carolina.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2M
MitoChem Therapeutics has raised a total of $2M in funding over 2 rounds. Their latest funding was raised on Apr 2, 2012 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 2, 2012 Seed $2M 1 Foundation Fighting Blindness Detail

Investors

Number of Lead Investors
Number of Investors
1
1
MitoChem Therapeutics is funded by 1 investors. Foundation Fighting Blindness are the most recent investors.
Investor Name Lead Investor Funding Round
Foundation Fighting Blindness Yes Seed